Brent Pfeiffenberger - Dec 4, 2023 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Role
President and CEO, Director
Signature
/s/ Michael Diem, Attorney-in-Fact
Stock symbol
IPSC
Transactions as of
Dec 4, 2023
Transactions value $
$0
Form type
4
Date filed
12/6/2023, 04:07 PM
Next filing
Mar 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction IPSC Common Stock Award $0 +1.17 M $0.00 1.17 M Dec 4, 2023 Direct F1
transaction IPSC Common Stock Award $0 +280 K +23.81% $0.00 1.45 M Dec 4, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IPSC Stock Option (right to buy) Award $0 +574 K $0.00 574 K Dec 4, 2023 Common Stock 574 K $1.61 Direct F3

Explanation of Responses:

Id Content
F1 Reflects a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutics, Inc.'s (the "Company's") common stock. The RSUs underlying this grant shall vest 25% on December 4, 2024, with the remaining 75% vesting in one-twelfth (1/12th) increments on each of the first trading days on or after each of February 15, May 15, August 15, and November 15, subject to the Reporting Person's continued service through each applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock.
F2 Reflects a grant of RSUs. The RSUs underlying this grant shall vest in full on December 4, 2024, subject to the Reporting Person's continued service through the applicable vesting date.
F3 The option vests 25% on December 4, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.